Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 7

1.

Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.

Wells SA Jr, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton SB, Ivanovich JL, DeBenedetti MK, Dilley WG, Moley JF, et al.

Ann Surg. 1994 Sep;220(3):237-47; discussion 247-50.

2.

Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10.

Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I, Toledo SP, Toledo RA, Tavares MR, Alevizaki M, Mian C, Siggelkow H, Hüfner M, Wohllk N, Opocher G, Dvořáková S, Bendlova B, Czetwertynska M, Skasko E, Barontini M, Sanso G, Vorländer C, Maia AL, Patocs A, Links TP, de Groot JW, Kerstens MN, Valk GD, Miehle K, Musholt TJ, Biarnes J, Damjanovic S, Muresan M, Wüster C, Fassnacht M, Peczkowska M, Fauth C, Golcher H, Walter MA, Pichl J, Raue F, Eng C, Neumann HP; International RET Exon 10 Consortium.

Hum Mutat. 2011 Jan;32(1):51-8. doi: 10.1002/humu.21385.

PMID:
20979234
3.

Clinical presentations and RET protooncogene mutations in seven multiple endocrine neoplasia type 2 kindreds.

Blank RD, Sklar CA, Dimich AB, LaQuaglia MP, Brennan MF.

Cancer. 1996 Nov 1;78(9):1996-2003.

PMID:
8909322
4.

Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases.

Etit D, Faquin WC, Gaz R, Randolph G, DeLellis RA, Pilch BZ.

Arch Pathol Lab Med. 2008 Nov;132(11):1767-73. doi: 10.1043/1543-2165-132.11.1767.

PMID:
18976013
5.

Mutational spectrum of multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma in taiwan.

Chang CF, Yang WS, Su YN, Wu IL, Chang TC.

J Formos Med Assoc. 2009 May;108(5):402-8. doi: 10.1016/S0929-6646(09)60084-X.

6.

Pheochromocytoma penetrance varies by RET mutation in MEN 2A.

Quayle FJ, Fialkowski EA, Benveniste R, Moley JF.

Surgery. 2007 Dec;142(6):800-5; discussion 805.e1. Epub 2007 Nov 5. Erratum in: Surgery. 2008 Feb;143(2):301.

PMID:
18063059
7.

RET proto-oncogene mutations in French MEN 2A and FMTC families.

Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes C, Modigliani E, Lenoir GM.

Hum Mol Genet. 1994 Nov;3(11):1939-43.

PMID:
7874109

Supplemental Content

Support Center